255 related articles for article (PubMed ID: 37278227)
1. Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations.
Ocran E; Chornenki NLJ; Bowman M; Sholzberg M; James P
Expert Rev Hematol; 2023; 16(8):575-584. PubMed ID: 37278227
[TBL] [Abstract][Full Text] [Related]
2. Special considerations in GI bleeding in VWD patients.
Chornenki NLJ; Ocran E; James PD
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):624-630. PubMed ID: 36485078
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal angiodysplasia and bleeding in von Willebrand disease.
Franchini M; Mannucci PM
Thromb Haemost; 2014 Sep; 112(3):427-31. PubMed ID: 24898873
[TBL] [Abstract][Full Text] [Related]
4. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease.
Makris M; Federici AB; Mannucci PM; Bolton-Maggs PHB; Yee TT; Abshire T; Berntorp E
Haemophilia; 2015 May; 21(3):338-342. PubMed ID: 25381842
[TBL] [Abstract][Full Text] [Related]
5. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal bleeding from angiodysplasia in von Willebrand disease: Improved diagnosis and outcome prediction using videocapsule on top of conventional endoscopy.
Rauch A; Paris C; Repesse Y; Branche J; D'Oiron R; Harroche A; Ternisien C; Castet SM; Lebreton A; Pan-Petesch B; Volot F; Claeyssens S; Chamouni P; Gay V; Berger C; Desprez D; Falaise C; Biron Andreani C; Marichez C; Pradines B; Zawadzki C; Itzhar Baikian N; Borel-Derlon A; Goudemand J; Gerard R; Susen S;
J Thromb Haemost; 2021 Feb; 19(2):380-386. PubMed ID: 33113216
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal angiodysplasia in two patients with type 3 von Willebrand disease.
Liao LC; Liao SC; Chang CH; Shih MY; Wang JD
Blood Coagul Fibrinolysis; 2019 Jul; 30(5):243-245. PubMed ID: 31261161
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal bleeding in von Willebrand disease.
Makris M
Thromb Res; 2006; 118 Suppl 1():S13-7. PubMed ID: 16542710
[TBL] [Abstract][Full Text] [Related]
9. [Association between von Willebrand disease and angiodysplasia].
Salinas Laval J; Triantafilo N; Zúñiga P
Rev Med Chil; 2020 Oct; 148(10):1475-1480. PubMed ID: 33844718
[TBL] [Abstract][Full Text] [Related]
10. Real-world healthcare costs and resource utilization in patients with von Willebrand disease and angiodysplasia.
Connell NT; Caicedo J; Nieto N; Chatterjee S; Hait A; Gupta AK; Bullano M; Schultz BG
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(6):691-699. PubMed ID: 37183836
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature.
Engelen ET; van Galen KP; Schutgens RE
Haemophilia; 2015 Jul; 21(4):419-29. PubMed ID: 25929157
[TBL] [Abstract][Full Text] [Related]
12. Targeting von Willebrand disease: the current status and future directions of management therapies.
Franchini M; Focosi D
Expert Rev Hematol; 2023; 16(11):871-878. PubMed ID: 37800892
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome.
Warkentin TE; Moore JC; Anand SS; Lonn EM; Morgan DG
Transfus Med Rev; 2003 Oct; 17(4):272-86. PubMed ID: 14571395
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor.
Inbal A; Bank I; Zivelin A; Varon D; Dardik R; Shapiro R; Rosenthal E; Shenkman B; Gitel S; Seligsohn U
Br J Haematol; 1997 Jan; 96(1):179-82. PubMed ID: 9012706
[TBL] [Abstract][Full Text] [Related]
16. Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.
Selvam S; James P
Semin Thromb Hemost; 2017 Sep; 43(6):572-580. PubMed ID: 28476066
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor.
Alhumood SA; Devine DV; Lawson L; Nantel SH; Carter CJ
Am J Hematol; 1999 Feb; 60(2):151-7. PubMed ID: 9929110
[TBL] [Abstract][Full Text] [Related]
18. Vascular abnormalities in patients with von Willebrand disease: A scoping review.
Chornenki NLJ; Shanjer M; James PD
J Thromb Haemost; 2021 Sep; 19(9):2151-2160. PubMed ID: 34060212
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia.
Randi AM
Thromb Res; 2016 May; 141 Suppl 2():S55-8. PubMed ID: 27207426
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand disease-associated angiodysplasia: a few answers, still many questions.
Franchini M; Mannucci PM
Br J Haematol; 2013 Apr; 161(2):177-82. PubMed ID: 23432086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
